His primary areas of study are Internal medicine, Breast cancer, Cancer, Oncology and Genome-wide association study. His Breast cancer research is multidisciplinary, incorporating perspectives in Prospective cohort study, Gynecology, Genetic predisposition and Risk factor. Argyrios Ziogas interconnects Ethnic origin and Surgery in the investigation of issues within Cancer.
His study in Oncology is interdisciplinary in nature, drawing from both Epidemiology, Case-control study and Gene mutation. His Genome-wide association study study is within the categories of Genetics and Single-nucleotide polymorphism. His Ovarian cancer study combines topics in areas such as Cancer research and Serous fluid.
His scientific interests lie mostly in Internal medicine, Oncology, Breast cancer, Cancer and Ovarian cancer. His Internal medicine research is multidisciplinary, relying on both Gynecology and Single-nucleotide polymorphism. Argyrios Ziogas combines subjects such as Epidemiology, Carcinoma, Proportional hazards model, Hazard ratio and Colorectal cancer with his study of Oncology.
His Breast cancer research integrates issues from Cancer research, Family history, Cohort and Genetic predisposition. His studies in Cancer integrate themes in fields like Survival analysis, Surgery, Guideline, Lung cancer and Risk factor. The study incorporates disciplines such as Endometriosis, Serous fluid, Clear cell and Prostate cancer in addition to Ovarian cancer.
Argyrios Ziogas mainly focuses on Internal medicine, Oncology, Breast cancer, Cancer and Ovarian cancer. Many of his studies on Internal medicine apply to Gynecology as well. His Oncology study combines topics from a wide range of disciplines, such as Epidemiology, Ovarian carcinoma, Case-control study, Allele and Prostate cancer.
His research integrates issues of CHEK2, Genome-wide association study, Bioinformatics and Medical genetics in his study of Breast cancer. His Cancer research includes elements of Cancer research, Guideline adherence, Guideline, Disease and Socioeconomic status. His Ovarian cancer research incorporates themes from Endometriosis, Serous fluid and Clear cell.
His primary scientific interests are in Breast cancer, Internal medicine, Oncology, Odds ratio and Genome-wide association study. His Breast cancer research also works with subjects such as
The concepts of his Oncology study are interwoven with issues in Epidemiology, Case-control study, Prostate cancer, Ovarian cancer and Radiation therapy. His studies deal with areas such as Lung cancer and Serous fluid as well as Ovarian cancer. His research in Genome-wide association study intersects with topics in Genetic predisposition and Medical genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Lower Cancer Incidence in Amsterdam-I Criteria Families Without Mismatch Repair Deficiency: Familial Colorectal Cancer Type X
Noralane M. Lindor;Kari Rabe;Gloria M. Petersen;Robert Haile.
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush.
American Journal of Human Genetics (2019)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Shahana Ahmed;Gilles Thomas;Maya Ghoussaini;Catherine S. Healey.
Nature Genetics (2009)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer.
Journal of the National Cancer Institute (2015)
Germ-line msh6 Mutations in Colorectal Cancer Families
Richard D. Kolodner;Jessica D. Tytell;James L. Schmeits;Michael F. Kane.
Cancer Research (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: